According to the current analysis of Reports and Data, the global Macrogol/Polyethylene Glycol (PEG) Market was valued at USD 3,212.1 million in 2018 and is expected to reach USD 4,934.6 million by year 2026, at a CAGR of 5.30%. Macrogol have been shown to provide water solubility and biocompatibility in medicines and different applications, and the ability to attach a range of reactive functional groups to the terminal positions of these polymers has greatly increased their utility. For instance, Macrogol 400 is very hydrophilic, which renders it a useful ingredient in drug formulations to augment the solubility and bioavailability of weakly water-soluble drugs.
The pharmaceutical industry is the emerging segment in this industry due to the fact of growing the manufacturing of eye drops and laxatives coupled with the increase of the pharmaceutical industry has improved the use of macrogol as a solvent which will force to increase the market growth in future. Besides, rising demand for water-based coatings and paints for utility in automobile and development industries has additionally elevated the demand for macrogol/polyethylene glycol. This will additionally have an on affect the market positively.
However, the presence of alternatives, for mono ethylene glycol (MEG) and a range of different glycol ethers, will pose a credible risk to the polyethylene glycol industry and negatively affect its future. The stringent environmental protocols associated to the manufacturing of private care and medical products may additionally obstruct the market boom for polyethylene glycol.
Receive a sample copy of the global market report, visit @ https://www.reportsanddata.com/sample-enquiry-form/1707
Key participants include – BASF, Sigma Aldrich, DOW Chemical Company, Lotte Chemical, Ineos, Croda, Liaoning Oxiranchem, Jiangsu Haian Petrochemical Plant, Shanghai Bronkow Chemical, and Oxiteno. BASF is a key player in the macrogol/polyethylene glycol (PEG) market. With a global presence in North America, Europe, Asia Pacific, and South America, Africa & Middle East, the company offers macrogols by the name – ‘Kollisolv’. As of 2018, the company’s total revenue accounted for USD 73.9 billion.
Further key findings from the report suggest
The PEG-3350 segment is projected to increase at a CAGR of 5.8% during the forecast period. This grade is used for short-term relief of constipation as well as for long-term use in constipation of various causes, including in multiple sclerosis and Parkinson's disease patients (an oftenoverlooked non-motor symptom) as well as constipation caused by pharmaceutical drugs such as opioids and anticholinergics.
Chronic constipation is a common disorder, affecting between 2-35% of the population, according to a recent report from European Review for Medical and Pharmacological Sciences. It is characterized by dry feces and infrequent excretions from the body. Macrogol improves stool frequency and consistency, thus making it a suitable drug to treat chronic constipation.
Receive Download Summary: https://www.reportsanddata.com/download-summary-form/1707
For the purpose of this report, Reports and Data has segmented the global macrogol/polyethylene glycol market on the basis of type, technology type, end use, and region:
Type (Volume, Metric Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
PEG 200
PEG 400
PEG 3350
PEG 4000
PEG 6000
PEG 8000
Others
Administration Route (Volume, Metric Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
Oral
Nasogastric
Ophthalmic
Topical
Usage (Volume, Metric Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
Excipient
API
End Use (Volume, Metric Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
Pharmaceutical Uses
Veterinary Health
Biotechnology
Biomedical
Other end uses
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/1707
Regional Outlook (Volume, Metric Tons; 2020-2028 and Revenue, USD Million; 2020-2028)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
